Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis

NCT01470664 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01470664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01470664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
December 17, 2012
Completion date
May 23, 2014
Enrollment
176 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute adenoviral conjunctivitis